Mountain Group Capital
Mountain Group Partners (MGP) is a private investment firm with family-office roots that invests primarily in healthcare and technology. The firm describes an active, long-term approach—supporting companies from early stages and participating in subsequent financings—focused on niche or underserved areas within their target industries.
Mountain Group Capital
Services
Equity investment (early to growth stages)
Leads and participates in venture financings across early and later rounds; example: led Series A for AN2 and participated in subsequent rounds.
Active operational & strategic support
Hands-on engagement providing operational and financial expertise, strategic advice and problem-solving during critical moments as companies scale.
Network and capital partner introductions
Facilitates introductions to co-investors, strategic partners and industry contacts; participates in syndicates and later-stage financings.
Equity investment (early to growth stages)
Leads and participates in venture financings across early and later rounds; example: led Series A for AN2 and participated in subsequent rounds.
Active operational & strategic support
Hands-on engagement providing operational and financial expertise, strategic advice and problem-solving during critical moments as companies scale.
Network and capital partner introductions
Facilitates introductions to co-investors, strategic partners and industry contacts; participates in syndicates and later-stage financings.
Portfolio
CEO Eric Easom provided a testimonial describing MGP as lead Series A investor and active participant in subsequent rounds.
#Biopharmaceuticals / Gene therapy
Testimonial notes MGP invested throughout founding to Castle’s IPO and helped commercialize diagnostic tests.
#Diagnostics / Genomic testing
Founder/CEO testimonial cites MGP’s domain knowledge and hands-on approach in animal health.
#Animal health / Veterinary therapeutics
MGP is a long-term partner; site includes multiple press items on solar projects and a Partners Group USD 100M investment into Silicon Ranch (Partners Group was a separate investor but items on mtngp reference Silicon Ranch activities).
#Renewable energy / Solar
CEO testimonial states MGP provided operational guidance enabling accelerated growth.
#Medical devices / Health IT (perceptible as medtech)
Covered clinical programs including Type 2 diabetes and NAFLD/NASH; received FDA Fast Track designation for NAFLD/NASH and ran Phase 2A trials (multiple news posts).
#Biopharma / Metabolic diseases (NAFLD, NASH, diabetes)
CEO Eric Easom provided a testimonial describing MGP as lead Series A investor and active participant in subsequent rounds.
#Biopharmaceuticals / Gene therapy
Testimonial notes MGP invested throughout founding to Castle’s IPO and helped commercialize diagnostic tests.
#Diagnostics / Genomic testing
Founder/CEO testimonial cites MGP’s domain knowledge and hands-on approach in animal health.
#Animal health / Veterinary therapeutics
MGP is a long-term partner; site includes multiple press items on solar projects and a Partners Group USD 100M investment into Silicon Ranch (Partners Group was a separate investor but items on mtngp reference Silicon Ranch activities).
#Renewable energy / Solar
CEO testimonial states MGP provided operational guidance enabling accelerated growth.
#Medical devices / Health IT (perceptible as medtech)
Covered clinical programs including Type 2 diabetes and NAFLD/NASH; received FDA Fast Track designation for NAFLD/NASH and ran Phase 2A trials (multiple news posts).
#Biopharma / Metabolic diseases (NAFLD, NASH, diabetes)